R&D Network in Oslo – Haematologic oncology
Welcome to our R&D networking meeting on haematological cancer.
The subject for this meeting is haematologic cancer, including Chronic Lymphatic Leukaemia (CLL) and Myelomatosis. We promise interesting international guest speakers as well as prominent Norwegian scientists and clinicians within the field of haematological cancer.
Moderator: Bjørn Tore Gjertsen fra Haukeland Universitetssykehus.
This meeting is arranged in collaboration with our members Takeda, Janssen and AbbVie.
Programme
14:00–14:30
Registration and light refreshments
14:30–15:00
Welcome and introduction by Professor Bjørn Tore Gjertsen, Haukeland University Hospital
Session I: Multiple Myeloma
15:00–15:20
Case presentations Multiple Myeloma
Moderator: Fredrik Schjesvold, Oslo
Kristina Anderson, Oslo
Fredrik Schjesvold, Oslo
15:20–16:00
Dr. Hareth Nahi, Karolinska Institutet, Stockholm: “Multiple myeloma: patient management, new agents, new treatments”
Short break
16:10–16:50
Prof Anders Waage, St. Olavs Hospital/ NTNU: “Clinical and Translational Studies in Multiple Myeloma”
Session II: Chronic Lymphatic Leukemia (CLL)
16:50–17:10
Case presentations Chronic Lymphatic Leukemia
Moderator: Prof Peter Meyer, Stavanger University hospital
Hoa Thi Tuyet Tran,Oslo
Aymen Ahmed, Bergen
17:10–17:50
Prof Carsten Utoft Niemann, Rigshospitalet, København: “A chemo-free future for managing CLL?”
17:50–19:00
Networking with light refreshments